(Q42993978)

12 November 2017

title

Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays (English)

1 reference

12 November 2017

1 reference

Jean-Michel Pawlotsky

1

1 reference

12 November 2017

Martinot-Peignoux M

2

1 reference

12 November 2017

Poveda JD

3

1 reference

12 November 2017

Bastie A

4

1 reference

12 November 2017

Le Breton V

5

1 reference

12 November 2017

Darthuy F

6

1 reference

12 November 2017

Rémiré J

7

1 reference

12 November 2017

Erlinger S

8

1 reference

12 November 2017

Dhumeaux D

9

1 reference

12 November 2017

Marcellin P

10

1 reference

12 November 2017

publication date

1 May 1999

1 reference

Journal of Virological Methods

12 November 2017

published in

1 reference

12 November 2017

volume

79

1 reference

12 November 2017

issue

2

1 reference

12 November 2017

page(s)

227-235

1 reference

Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA.

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900024-5

7 January 2021

Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900024-5

7 January 2021

Diagnostic tests for hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900024-5

7 January 2021

Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900024-5

7 January 2021

Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900024-5

7 January 2021

Comparison of quantitative HCV RNA assays in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900024-5

7 January 2021

Implications of variations of "conserved" regions of hepatitis C virus genome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900024-5

7 January 2021

Quantitative measurement of serum HCV RNA in patients with chronic hepatitis C: comparison between Amplicor HCV monitor system and branched DNA signal amplification assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900024-5

7 January 2021

Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900024-5

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900024-5

7 January 2021

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900024-5

7 January 2021

Measuring hepatitis C viremia in clinical samples: can we trust the assays?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900024-5

7 January 2021

Factors affecting treatment responses to interferon-alpha in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900024-5

7 January 2021

What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900024-5

7 January 2021

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900024-5

7 January 2021

Levels of hepatitis C virus in blood donors infected with different viral genotypes. International HCV Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900024-5

7 January 2021

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900024-5

7 January 2021

10.1016/S0166-0934(99)00024-5

Identifiers

DOI

1 reference

12 November 2017

1 reference